title: Brief Report About the Role of Hyperthermic Intraperitoneal Chemotherapy in a Prospective Randomized Phase 3 Study in Recurrent Ovarian Cancer From Spiliotis et al.
abstract: A published so-called phase 3 study regarding HIPEC in ovarian cancer raised multiple questions. This commentary focusses on the weakness of the publication and discusses this in detail.
authors.affiliation: *Department of Gynecology & Gynecologic Oncology, Kliniken Essen Mitte, Essen; †Coordinating Center for Clinical Trials, Philipps-University Marburg, Marburg; ‡Department of Gynecology, Charité, Berlin, Germany; and §Department of Gynecology Oncology, MD Anderson Cancer Center, Madrid, Spain.
authors.forename: Philipp
authors.initials: P
authors.lastname: Harter
authors.forename: Alexander
authors.initials: A
authors.lastname: Reuss
authors.forename: Jalid
authors.initials: J
authors.lastname: Sehouli
authors.forename: Luis
authors.initials: L
authors.lastname: Chiva
authors.forename: Andreas
authors.initials: A
authors.lastname: du Bois
mesh_terms: D000077216:Carcinoma, Ovarian Epithelial; D003131:Combined Modality Therapy; D065426:Cytoreduction Surgical Procedures; D005260:Female; D006801:Humans; D006979:Hyperthermia, Induced; D009364:Neoplasm Recurrence, Local; D010051:Ovarian Neoplasms; D011446:Prospective Studies